Range Cancer Therapeutics ETF (NQ:CNCR)

9.020 UNCHANGED

Last Price Updated: 4:15 PM EDT, May 27, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Range Cancer Therapeutics ETF

Why Did CANF Stock Soar 40% In Pre-Market Today? ↗

March 04, 2026

The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint.

Via Stocktwits

IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers ↗

November 10, 2025

Via Stocktwits

Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments ↗

November 03, 2025

Via Stocktwits

Vor Bio Stock Jumped 19% Today And Retail Investors Are Eyeing A Breakout Rally: Here’s What’s Happening ↗

August 13, 2025

Via Stocktwits

3 Top-Ranked ETFs Under $20 For Your Portfolio ↗

June 07, 2024

Let us dig into some of the ETFs that are below $20 and have a strong buy rating. These low-priced ETFs could lead to huge gains in the coming months based on market trends.

Via Talk Markets

Topics ETFs

5 Market-Beating Sector ETFs Of Q1 ↗

March 27, 2024

Here are some of the top performers in the ETF space from different sectors of the market.

Via Talk Markets

Topics ETFs

5 Sector ETFs Beating The Market Halfway Through Q1 ↗

February 12, 2024

After a weak start to 2024, Wall Street regained momentum, with all three major indices logging their fifth straight week of gains.

Via Talk Markets

Topics ETFs

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

5 Top-Ranked ETFs To Buy At Bargain Prices For 2023 ↗

January 04, 2023

Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend.

Via Talk Markets

5 ETFs Riding High On The Biotech Comeback ↗

July 09, 2022

The high-growth biotech segment has borne the maximum brunt of the broader market sell-off.

Via Talk Markets

3 Promising Oncology Stocks To Consider Adding To Your Portfolio ↗

June 14, 2021

With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.

Via Talk Markets

Best Biotech Stocks & ETFs for mRNA, Gene Editing ↗

April 29, 2021

2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.